When the Mission Meets the Market: The Governance Test of AI's Coming IPOs

Fourteen months after Sam Altman wrote that OpenAI's nonprofit control "will not change," the company is preparing to file for an initial public offering targeting a September 2026 listing - a move that will introduce a new class of stakeholder whose legal duty has never included the long-term benefit of humanity.^[2] The commitment and the filing are not obviously compatible. That tension is what this article is about.

In the spring of 2025, OpenAI's board posted a letter to employees explaining why the nonprofit would retain control after converting its operating arm to a Public Benefit Corporation. "OpenAI was founded as a nonprofit," Altman wrote, "is today a nonprofit that oversees and controls the for-profit, and going forward will remain a nonprofit that oversees and controls the for-profit. That will not change."^[1] Anthropic, which has its own mission-first governance architecture and a valuation that recently crossed $965 billion, faces the same test, with a listing now possible in late 2026 and more likely in 2027.^[3]

The question isn't whether these companies should go public. The capital needs are real, the technology is genuinely consequential, and access to public markets is a rational response to a competitive environment that punishes hesitation. The question is whether the governance structures both companies have built are durable enough to survive the particular pressures that public ownership applies - not in a single dramatic moment, but in the accumulation of quarterly calls, analyst downgrades, and proxy fights that define the life of a listed company.

What the architecture actually says

OpenAI's post-conversion structure is more constrained than its original December 2024 proposal, and that constraint came from external pressure. After engagement from the offices of the Attorneys General of California and Delaware, the company walked back a plan that would have severed nonprofit control entirely. Under the structure that completed in October 2025, the OpenAI Foundation holds a 26% equity stake in OpenAI Group PBC - valued at roughly $130 billion at the current private mark - and retains formal governance authority over the for-profit entity.^[4] Employees and investors hold the remaining 74%, with current and former employees holding approximately 47%.

The PBC designation is real but limited. Delaware law permits PBC directors to weigh public benefit against shareholder interests; it does not require them to do so in any specific way, and it provides no external enforcement mechanism for mission commitments beyond what the nonprofit's own board chooses to exercise. The Foundation's 26% stake gives it genuine blocking power in major decisions, but 26% is a minority position in all but existential votes. What it cannot do is prevent the gradual reorientation of priorities that happens when a company faces quarterly earnings scrutiny.

Anthropic's Long-Term Benefit Trust is a more structurally ambitious experiment. The Trust holds a special class of stock (Class T) that grants it the authority to elect - and ultimately control - a majority of Anthropic's board, phased in over time.^[5] The five Trustees are financially disinterested in Anthropic's stock price by design, insulated from the incentive alignment that makes most governance structures drift toward shareholder primacy. It is, as Anthropic openly acknowledges, an experiment - with explicit "failsafe" provisions allowing supermajority stockholders to amend the structure if the experiment fails.

The LTBT is meaningfully stronger than OpenAI's arrangement. But it was designed for a private company. Its resilience as a public-company governance mechanism, under the sustained pressure of institutional shareholders, activist funds, and index-fund stewardship demands, has never been tested.

The financial reality that public markets will price

Neither company's financials make the governance question purely theoretical. They make it urgent.

OpenAI generated $5.7 billion in revenue in the first quarter of 2026 - a run rate that implies roughly $23 billion annualized - against a non-GAAP operating margin of negative 122%.^[6] That figure excludes stock-based compensation, which at an average of $1.5 million per employee across a 4,000-person workforce represents another $6 billion in annual obligation.^[7] The company's own projections forecast cumulative losses of roughly $44 billion between 2023 and the end of 2028, with a path to profitability contingent on reaching $30 billion in 2026 revenue and maintaining revenue growth rates that have recently shown signs of deceleration. Weekly active ChatGPT users averaged 905 million in Q1, below the 1 billion target OpenAI set for 2025, and the conversion rate from free to paid users remains approximately 6%.^[6]

The company has committed to spending approximately $600 billion on compute through 2030 - a figure that Altman originally framed as $1.4 trillion before revising downward - and has already secured roughly $122 billion in committed capital including a $40 billion SoftBank bridge loan.^[8] OpenAI's own CFO, Sarah Friar, has privately flagged concerns about organizational readiness for a 2026 listing and questioned whether the aggressive infrastructure spending can be justified by current revenue trends. Friar's stated preference is a 2027 IPO; Altman wants the offering by Q4 2026.^[9]

The internal disagreement is itself instructive. The same capital pressure that drives the IPO ambition is creating friction between the CEO's growth imperatives and the CFO's concerns about financial discipline. That tension doesn't resolve itself at listing - it becomes a permanent feature of the public company's life, adjudicated every 90 days.

Anthropic's finances tell a story of exceptional velocity but equally exceptional burn. Its run-rate revenue reached $19 billion in March 2026, had crossed $30 billion earlier this year, and by the time the company closed its Series H in late May had surpassed $47 billion - a trajectory with few modern precedents.^[10] That growth is driven heavily by enterprise API contracts and Claude Code, which alone generates an estimated $2.5 billion annualized.^[10] The company's burn is significant - an estimated $8-12 billion in 2026 - but its path to operating breakeven is modeled at 2027 or 2028. The revenue composition is also higher-quality than OpenAI's: enterprise and developer contracts with genuine switching costs, rather than a consumer chatbot app with a 6% monetization rate.

But Anthropic is not a clean story either. Its Series H closed at a $965 billion valuation in May 2026. Divide that by $47 billion in run-rate revenue and the implied multiple is roughly 20x - before any public-market step-up. That multiple is not outlandish for a company growing at Anthropic's pace, but it is built on a growth narrative that leaves very little room for deceleration. For comparison, even the highest-quality public AI infrastructure companies have rarely sustained multiples above 15x when growth has slowed.

The Altman question

Any honest analysis of OpenAI's IPO has to address the specific governance implications of Sam Altman's stake. For years, Altman publicly stated he held no equity in OpenAI - a claim that was always somewhat unusual for a CEO, and which was central to the argument that he was uniquely motivated by mission rather than personal financial interest. In court testimony during the Musk litigation, Altman acknowledged holding a passive stake through Y Combinator, the venture fund he ran before joining OpenAI. The restructuring and IPO preparation have surfaced further questions about his position: if Altman holds a meaningful equity stake at a $1 trillion valuation, the incentive structure of OpenAI's leadership looks considerably more conventional than its governance documents suggest.^[11]

This is not a claim that Altman is acting in bad faith. A CEO with significant equity in a company he leads is the norm, not an aberration. But it matters for how to read the nonprofit's retained control. If the Foundation's 26% stake is exercised by a board that includes people with large personal financial stakes in OpenAI's stock performance, the independence of that oversight is structurally compromised - regardless of the legal framework. The attorneys general of California and Delaware extracted the nonprofit-control commitment through regulatory pressure. Whether that commitment has teeth in practice will be tested in the years after listing, not before.

What public markets actually do to mission companies

The historical record on mission-driven companies going public is not encouraging, though it is not uniformly bleak either. The pattern is rarely dramatic apostasy. It is incremental accommodation.

Benefit corporations and mission-embedded structures have generally weathered their first few years of public life without obvious mission betrayal. What they have struggled with is the compounding cost of underperformance: when a mission-driven company misses earnings, the institutional response is not to applaud the principled tradeoffs - it is to demand changes. Management teams that face sustained pressure to improve margins tend to find ways to reframe safety and mission work as costs rather than assets. Product decisions get made faster. Deployment timelines accelerate. The word "responsible" appears more frequently in earnings calls precisely because it is doing less work in practice.

The most plausible risk for both OpenAI and Anthropic is not that they abandon their safety commitments in a single vote. It is that those commitments become increasingly nominal over time as the financial pressure to perform accumulates. The governance structures both companies have built are designed to prevent the former. Neither is well-designed to prevent the latter.

A legitimate case for optimism

It would be intellectually dishonest to present the governance risk without acknowledging the countervailing arguments, and they are real.

First, the alternative to a well-capitalized, publicly accountable OpenAI or Anthropic is not a well-capitalized, mission-pure version of the same companies - it is a landscape where the frontier is defined entirely by less mission-conscious actors. The compute economics of frontier AI make underfunding a safety-oriented lab a more dangerous outcome than the governance dilution that an IPO brings. Anthropic's founders understood this when they left OpenAI in 2021; their entire strategic theory rests on the argument that mission-driven labs need to be at the frontier to have any influence on how the frontier develops.

Second, the LTBT specifically, and the PBC structure generally, are genuinely novel instruments. Anthropic's trust has already demonstrated independence in its governance decisions, even amid the company's rapid commercial growth. The initial trustees were chosen from backgrounds - AI safety research, public health, national security - that give them both the expertise and the insulation from financial incentive to exercise real judgment. The structure has failsafes, but those failsafes require large supermajorities to exercise; they are not easy exits for impatient shareholders. The more probing question is whether trustee independence, however structurally protected, can hold against the sustained, diffuse pressure of institutional shareholder expectations rather than any single high-stakes vote.

Third, the regulatory environment has changed. The attorneys general engagement that shaped OpenAI's restructuring was not a one-time intervention; it established a precedent for ongoing state oversight of AI company governance. Illinois has now passed legislation requiring independent safety audits of frontier AI labs, and Governor Pritzker has stated his intention to sign it into law.^[12] A company that visibly abandons its safety mission post-IPO faces not just reputational risk but regulatory exposure in multiple jurisdictions.

The test that matters

The governance structures of OpenAI and Anthropic will be tested not by the IPO itself, but by what happens in the first two to three years after listing. Specifically, by three scenarios that both companies should prepare investors to understand before they list.

First: what happens when a safety finding requires delaying or restricting a lucrative product launch? The answer to that question - whether the delay happens, and how it is explained - will tell public market observers more about governance durability than any S-1 disclosure.

Second: what happens when a major shareholder files a proposal to weaken the governance structure? Both the Foundation's stake and the LTBT create legal obstacles to such a proposal succeeding, but the institutional response - whether the board engages or dismisses - will signal the seriousness of the underlying commitment.

Third: what happens to safety research funding when the company misses a revenue quarter? Safety and alignment work is expensive and its returns are diffuse. It is precisely the kind of expenditure that faces pressure in a public company with a 122% negative operating margin. Maintaining that investment through earnings pressure is the clearest possible demonstration that the mission governance is real.

Neither company has committed to public reporting on any of these scenarios. That gap - between elaborate governance structures and transparent accountability for how those structures actually function - is the most important thing missing from the IPO narrative. And it is worth remembering what Altman promised: that the nonprofit oversight "will not change." How those three tests are resolved will determine whether that sentence was a commitment or a curtain call.

AI Policy